NewAmsterdam Pharma Company N.V. (NAMS)

NASDAQ: NAMS · Real-Time Price · USD

Compare

35.97

+0.45 (1.27%)

At close: Dec 4, 2025, 4:00 PM EST

35.85

-0.12 (-0.33%)

After-hours: Dec 4, 2025, 5:41 PM EST

NAMS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	538.41	771.74	340.45	467.73	60.38	9.62
Short-Term Investments	164.54	62.45	-	-	-	-
Cash & Short-Term Investments	702.95	834.19	340.45	467.73	60.38	9.62
Cash Growth	66.29%	145.03%	-27.21%	674.64%	527.92%	-
Other Receivables	20.25	21.31	1.88	2.07	4.88	-
Receivables	20.25	21.31	1.88	2.07	4.88	-
Prepaid Expenses	7.83	7.92	4.46	8.18	1.7	1.66
Total Current Assets	732.33	863.41	346.79	477.98	66.96	11.28
Property, Plant & Equipment	0.57	0.67	0.1	0.15	0.22	0.01
Other Intangible Assets	0.44	0.53	0.17	0.21	-	-
Other Long-Term Assets	-	-	0.04	0.16	-	-
Total Assets	786.43	864.62	347.1	478.5	67.99	11.29
Accounts Payable	3.63	4.74	16.92	11.85	7.07	0.48
Accrued Expenses	10.1	13.61	11.4	6.12	4.1	0.93
Short-Term Debt	-	-	-	-	-	14.25
Current Portion of Leases	0.18	0.25	0.06	0.07	0.06	-
Current Unearned Revenue	-	6.01	8.94	13.87	-	-
Other Current Liabilities	44.36	82.31	12.57	4.15	-	-
Total Current Liabilities	58.27	106.92	49.9	36.06	11.24	15.67
Long-Term Leases	0.09	0.2	-	0.06	0.13	-
Long-Term Unearned Revenue	-	-	1.02	4.79	-	-
Other Long-Term Liabilities	-	-	7.79	7.52	-	-
Total Liabilities	58.36	107.12	58.7	48.43	11.36	15.67
Common Stock	14.11	13.44	10.17	10.06	0.13	0.06
Additional Paid-In Capital	1,397	1,298	590.77	555.63	95.26	3
Retained Earnings	-687.47	-558.57	-316.97	-140.04	-39.44	-7.43
Comprehensive Income & Other	4.64	4.47	4.42	4.42	0.67	-
Shareholders' Equity	728.07	757.5	288.39	430.07	56.63	-4.38
Total Liabilities & Equity	786.43	864.62	347.1	478.5	67.99	11.29
Total Debt	0.27	0.45	0.06	0.13	0.19	14.25
Net Cash (Debt)	755.77	833.74	340.39	467.6	60.19	-4.63
Net Cash Growth	79.00%	144.94%	-27.21%	676.83%	-	-
Net Cash Per Share	6.67	8.84	4.14	24.65	5.48	-0.93
Filing Date Shares Outstanding	113.39	109.82	89.27	81.77	11.33	5
Total Common Shares Outstanding	113.17	108.06	82.47	81.56	11.33	5
Working Capital	674.06	756.5	296.89	441.92	55.72	-4.39
Book Value Per Share	6.43	7.01	3.50	5.27	5.00	-0.88
Tangible Book Value	727.63	756.97	288.22	429.86	56.63	-4.38
Tangible Book Value Per Share	6.43	7.00	3.49	5.27	5.00	-0.88
Machinery	-	-	-	-	0.04	0.02

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q